Proton Therapy in Cancer: Global Markets

Report Code: HLC250A

Publish Date: Jan 2020

Publisher: BCC Publishing

Category: Health Maintenance

Customize This Report

Single User License: $2500

Member Price: FREE

EXPLORE OFFERS

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global proton therapy market for cancer reached $671.6 million in 2019 and should reach $1.2 billion by 2024, at a compound annual growth rate (CAGR) of 13.1% for the period of 2019-2024.

Report Includes

  • 55 data tables and 25 additional tables
  • A comprehensive overview of the global markets for proton therapy or proton beam therapy (PBT) in cancer treatment
  • Analyses of global market trends with data from 2018, estimates for 2019, and projections of compound annual growth rates (CAGRs) through 2024
  • Coverage of historical data; effectiveness, clinical benefits and side effects (for treating malignancies) of proton technology; and key role plays across various cancers
  • Retrospective study outlining difference between proton-based therapy and conventional intensity modulated radiation therapy (IMRT), cost effectiveness for specific patients such as children, and clinical advances in hematology and oncology
  • Assessment of recent breakthroughs, current R&D activities, rapid technological advances in PBT, expanding utilization of image-guided proton therapy, and latest trends related to this field of clinical research
  • Patent review and new developments in PBT technologies
  • Company profiles of leading market participants within the industry, including Elekta Instrument AB, Hitachi, Ltd., Mevion Medical Systems, Inc., Pronova Solutions, Llc, Protom International, Raysearch Laboratories Ab and Varian Medical Systems, Inc.

Report Scope

This report provides a comprehensive analysis of the proton therapy market in global context, including market forecasts and sales through 2024. The report analyzes the market by segmenting it into the various types of room types (single-room and multi-room). The end-user markets focus on hospitals, proton therapy centers and others. This study surveys the proton therapy market according to various types of cancers (by application), i.e., pediatric cancers, skull base treatment, central nervous system, head and neck cancer, prostate cancer, sarcomas, lung cancer and others. The proton therapy market is also assessed by geographic region including North America, Europe and emerging markets. Emerging markets includes countries in Africa, Asia and South America.

This report details new developments and patents boosting the growth of this market in the global context. A list of leading proton therapy centers, their locations and other details is also provided.

This report also provides comprehensive profiles of market players in the industry. The industry structure chapter focuses on the changing market trends, leading vendors, their market shares and product offerings. This chapter also covers mergers and acquisitions and any other collaborations or partnerships that happened during the forecast period and which are expected to shape the industry.

Factors such as strengths, weaknesses, threats and opportunities that are expected to play a role in the proton therapy market are evaluated in detail.

Excluded from this report are the traditional radiation therapy equipment suppliers. The carbon ion therapy is still a very small market and is thus not included with proton therapy.

Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Analyst Credentials

Dr. Kamna Jhamb has more than 13 years of research experience, of which more than four years have been devoted to market research. Before entering the field of market research, she worked as a Research Assistant in Lawrence Berkeley National Lab, CA. With a Ph.D. in Microbial Technology, she has vast knowledge in the areas of microbiology, protein chemistry, and molecular biology. She has several international publications in reputed journals. For BCC Research, Dr. Kamna has written reports spanning topics from healthcare, finance, to biotechnology.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Proton Therapy in Cancer: Global Markets178Free
Chapter- 1: Introduction9Free
Chapter- 2: Summary and Highlights3Free
Chapter- 3: Market and Technology Background18Free
Chapter- 4: Market Breakdown by Type of System and Technology21Free
Chapter- 5: Market Breakdown by Region26Free
Chapter- 6: Market Breakdown by End User10Free
Chapter- 7: Market Breakdown by Type of Cancer Treated23Free
Chapter- 8: Industry Structure15Free
Chapter- 9: Clinical Trials on Proton Therapy8Free
Chapter- 10: Proton Therapy Centers and Patient Volume13Free
Chapter- 11: Patent Analysis7Free
Chapter- 12: Analysis of Market Opportunities13Free
Chapter- 13: Company Profiles8Free
Chapter- 14: Appendix: Acronyms4Free

Related Reports

Global Oncology Pharmaceuticals Market

Published - Oct 2024 | Publisher - BCC Publishing | Code - PHM256B

The global market for oncology pharmaceuticals is estimated to increase from $196.4 billion in 2023 to reach $401.4 billion by 2029, at a compound annual growth rate (CAGR) of 12.7% from 2024 through 2029.

Radiotherapy, Radiopharmaceuticals and Nuclear Medicine: Global Markets

Published - Jul 2024 | Publisher - BCC Publishing | Code - HLC176E

The global market for radiation therapy products and radiopharmaceuticals is expected to grow from $17.5 billion in 2024 and is projected to reach $31.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.3% during the forecast period of 2024 to 2029.

Diagnostics and Therapeutics for Lung Cancer: Global Markets

Published - May 2015 | Publisher - Vijay Laxmi | Code - PHM174A

The global market for lung cancer grew to $21.9 billion in 2014 from $20.3 billion in 2013. The market is expected to grow at a five-year compound annual growth rate (CAGR) of 7.8% from 2014 to 2019, totaling $31.8 billion in 2019.

Recent Reports

Conventional and Alternative Pain Treatment Markets

Published - Nov 2024 | Publisher - Partha Sarathi Das | Code - HLC266B

The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.

CRISPR Technology: Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC258C

The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC239C

The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.

Medical Devices: Technologies and Global Markets

Published - Oct 2024 | Publisher - Partha Sarathi Das | Code - HLC170F

The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.

Point-of-Care Diagnostics: Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC043H

The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.

Top Trending Reports

AI in Clinical and Molecular Diagnostics Market

Published - Oct 2024 | Publisher - BCC Publishing | Code - BIO261A

The global market for AI in clinical and molecular diagnostics is expected to grow from $2.6 billion in 2024 and is projected to reach $8.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.6% during the forecast period of 2024 to 2029.

Point-of-Care Diagnostics: Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC043H

The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.

Medical Devices: Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC170F

The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.

Global Artificial Intelligence (AI) Market: Investments vs Potential

Published - Aug 2024 | Publisher - BCC Publishing | Code - IFT189C

The global market for artificial intelligence (AI) is estimated to increase from $148.8 billion in 2023 to reach $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 39.7% from 2024 through 2029.

CRISPR Technology: Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC258C

The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Proton Therapy in Cancer: Global Markets
Customize Report